文献速递角膜与眼表疾病

穿透性角膜移植与深板层角膜移植长期植片存活率比较研究

Comparative Study of Long-term Graft Survival Between Penetrating Keratoplasty and Deep Anterior Lamellar Keratoplasty.
PubMed 文献 · Am J Ophthalmol · 2020-11-27

该回顾性临床队列研究比较了新加坡角膜移植研究中362例深板层角膜移植(DALK)和307例穿透性角膜移植(PK)的10年植片存活率。结果显示DALK的10年存活率(93.9%)显著高于PK(72.0%),且PK术后青光眼、排斥反应、上皮问题和免疫性失败发生率均更高。结论支持在角膜内皮功能正常时优先选择DALK。

要点

  • PK术后青光眼(29.3% vs 11.6%)和排斥反应(16.6% vs 1.7%)发生率显著高于DALK。

核心结论

  • 对于角膜内皮功能正常的角膜病变,初次DALK的10年植片存活率优于PK。
  • DALK术后并发症更少,植片排斥和失败率更低,支持在可能时优先选择DALK而非PK。

研究设计与样本

  • 回顾性临床队列研究,纳入新加坡角膜移植研究中连续初次光学性角膜移植病例,DALK组362例,PK组307例。
  • 排除诊断为内皮病变的病例,比较10年植片存活结局,主要指标为平均植片存活率。

临床怎么用

  • 对于角膜内皮功能正常的角膜病变,应优先考虑DALK以降低远期植片失败和并发症风险。
  • PK术后需更密切监测青光眼、排斥反应和上皮问题。

局限性

  • 本研究为回顾性队列研究,可能存在选择偏倚。
  • 研究排除了内皮病变病例,结论仅适用于内皮功能正常的角膜病变。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Endothelial failure and immunological graft rejection remain long-term complications leading to late graft failure in penetrating keratoplasty (PK). Deep anterior lamellar keratoplasty (DALK) has emerged as a viable alternative that enables preservation of the host's endothelial cells to eliminate risks of endothelial rejection and failure. The aim of this study was to compare long-term graft survival between PK and DALK. DESIGN: Retrospective clinical cohort study. METHODS: All consecutive primary grafts of DALKs (n = 362) and PKs (n = 307) performed for optical indications in a tertiary eye center from the ongoing, prospective Singapore Corneal Transplant Study. Ten-year graft survival outcomes were compared. Cases in which endothelial pathologies were diagnosed were excluded, as DALK was not performed for such cases. Main outcome measurements were mean graft survival rate. RESULTS: The survival rate for PK was 94.4%, 80.4%, and 72.0% at 1, 5, and 10 years, respectively; and 95.8%, 93.9%, and 93.9% at 1, 5, and 10 years, respectively, for DALK (P = .001). Patients who underwent PK developed more complications of glaucoma (29.3% vs. 11.6%, respectively; P < .001), allograft rejection (16.6% vs. 1.7%, respectively; P < .001), epithelial problems (10.4% vs. 5.5%, respectively; P = .018), and nonimmunological failure (7.8% vs. 1.9%, respectively; P < .001), compared to DALK. Rates of graft failure attributable to rejection (36.7% vs. 5.9%, respectively; P = .015) and endothelial failure (36.7% vs. 5.9%, respectively; P = .015) were lower in DALK. CONCLUSIONS: The 10-year graft survival for primary DALK was superior to that for PK for corneal pathologies with functional endothelium. Primary DALK resulted in fewer post-operative complications and lower rates of graft rejection and failure. This study strengthens the case in favor of performing DALK over PK when possible.

来源:Am J Ophthalmol,查看原文。版权归原作者所有。

引用

  1. Arundhati A, Chew MC, Lim L, et al. Comparative Study of Long-term Graft Survival Between Penetrating Keratoplasty and Deep Anterior Lamellar Keratoplasty. Am J Ophthalmol. 2020. PMID: 33253665. doi:10.1016/j.ajo.2020.11.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。